Physical activity levels of adult hematologic cancer patients are deficient. The resulting physical inactivity causes fatigue, muscle loss, and deterioration in physical performance values. However, physical exercise programs still play a minor role in treating hematological malignancies. In addition, there are no reliable data in the literature regarding risk factors, feasibility, and exercise results in individuals with hematological malignancies. Although it is known that the use of corticosteroids, which are among the drugs given during chemotherapy, causes muscle weakness, there are no physical exercise programs performed with this patient group in the literature. The current study aims to compare the effects of resistance exercise and resistance exercise combined with neuromuscular electrical stimulation on muscle strength, functional lower extremity strength, and mobility in hematological cancer patients during chemotherapy.
Inclusion Criteria: * Diagnosed with hematological cancer, * ≥ 18 years old * ECOG Performance Status to be between 1-3 * Hemoglobin; 8-10gr / dl and over * Receiving platelet support related to thrombocytopenia and/or having a platelet value of 20.000 mm3 or more * Leukocyte (WBC) count being 3000 μL and above * Giving written consent to participate in the study Exclusion Criteria: * Comorbidities that cause fatigue (eg multiple sclerosis, Parkinson's disease, heart failure) * Presence of previously diagnosed heart disease * Using a pacemaker * Rapid deterioration of the general condition (sudden uncontrolled weight loss, confused consciousness, high C reactive protein (CRP) values) * Brain metastasis or femoral bone metastasis * Having dementia or psychotic condition * Being depressed and /or taking medication to treat depression * Presence of epilepsy * Presence of neuropathy * Having sensory defects in the NMES application area * Denying NMES application